# Mannkind Corp: filings

MNKD · Nasdaq · CIK 899460 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mnkd.md) · [Financials](/companies/mnkd/financials.md) · [Filings](/companies/mnkd/filings.md) · [Insiders](/companies/mnkd/insiders.md)

## Reports and events: 343 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 709, 8-K 238, 10-Q 53, 144 48, 4/A 47, 3 24, DEF 14A 21, 424B5 20, SC 13G/A 20, 5 19, 10-K 18, DEFA14A 17, UPLOAD 12, CORRESP 10, S-8 9, 8-K/A 8, CT ORDER 8, PRE 14A 8, SC 13G 8, ARS 6, EFFECT 5, SC TO-T/A 5, FWP 4, S-3 4, S-3ASR 4, POSASR 3, SC TO-C 3, 10-K/A 2, 424B7 2, SCHEDULE 13G 2, 10-Q/A 1, 144/A 1, 5/A 1, D 1, DEFR14A 1, NT 10-K 1, S-1 1, SC 13D/A 1, SCHEDULE 13G/A 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-21 | 16:10 ET | [8-K](/filings/0001193125-26-361105.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-361105 |
| 2026-08-05 | 16:07 ET | [10-Q](/filings/0001193125-26-335054.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335054 |
| 2026-08-05 | 16:03 ET | [8-K](/filings/0001193125-26-335016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335016 |
| 2026-07-24 | 16:01 ET | [8-K](/filings/0001193125-26-316041.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-316041 |
| 2026-06-02 | 08:00 ET | [8-K](/filings/0001193125-26-252544.md) | 8.01 Other events | 0001193125-26-252544 |
| 2026-05-28 | 08:37 ET | [8-K](/filings/0001193125-26-243074.md) | 8.01 Other events | 0001193125-26-243074 |
| 2026-05-22 | 17:17 ET | [8-K](/filings/0001193125-26-237183.md) | 5.07 Shareholder vote results | 0001193125-26-237183 |
| 2026-05-06 | 16:05 ET | [10-Q](/filings/0001193125-26-208916.md) | Quarterly report, period 2026-03-31 | 0001193125-26-208916 |
| 2026-05-06 | 16:03 ET | [8-K](/filings/0001193125-26-208910.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208910 |
| 2026-04-07 | 16:30 ET | [DEF 14A](/filings/0001193125-26-145613.md) | Proxy statement, period 2026-04-07 | 0001193125-26-145613 |
| 2026-02-26 | 08:06 ET | [10-K](/filings/0001193125-26-073516.md) | Annual report, period 2025-12-31 | 0001193125-26-073516 |
| 2026-02-26 | 08:03 ET | [8-K](/filings/0001193125-26-073509.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-073509 |
| 2025-12-15 | 16:02 ET | [8-K/A](/filings/0001193125-25-319170.md) | 9.01 Financial statements and exhibits | 0001193125-25-319170 |
| 2025-11-10 | 08:05 ET | [8-K](/filings/0001193125-25-273321.md) | 8.01 Other events | 0001193125-25-273321 |
| 2025-11-05 | 08:06 ET | [10-Q](/filings/0001193125-25-265813.md) | Quarterly report, period 2025-09-30 | 0001193125-25-265813 |
| 2025-11-05 | 08:03 ET | [8-K](/filings/0001193125-25-265810.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265810 |
| 2025-10-09 | 17:17 ET | [8-K](/filings/0001193125-25-236064.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-236064 |
| 2025-08-27 | 08:08 ET | [8-K](/filings/0000950170-25-111586.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-111586 |
| 2025-08-25 | 07:33 ET | [8-K](/filings/0001193125-25-186994.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-186994 |
| 2025-08-06 | 07:15 ET | [10-Q](/filings/0000950170-25-103535.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103535 |
| 2025-08-06 | 07:10 ET | [8-K](/filings/0000950170-25-103532.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103532 |
| 2025-05-19 | 17:02 ET | [8-K](/filings/0000950170-25-074523.md) | 5.07 Shareholder vote results | 0000950170-25-074523 |
| 2025-05-15 | 16:08 ET | [8-K](/filings/0001193125-25-120797.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-120797 |
| 2025-05-08 | 08:10 ET | [10-Q](/filings/0000950170-25-066429.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066429 |
| 2025-05-08 | 08:08 ET | [8-K](/filings/0000950170-25-066426.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066426 |
| 2025-04-01 | 17:00 ET | [DEF 14A](/filings/0000950170-25-048683.md) | Proxy statement, period 2025-05-14 | 0000950170-25-048683 |
| 2025-02-26 | 16:10 ET | [10-K](/filings/0000950170-25-027735.md) | Annual report, period 2024-12-31 | 0000950170-25-027735 |
| 2025-02-26 | 16:07 ET | [8-K](/filings/0000950170-25-027721.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-027721 |
| 2025-01-06 | 17:09 ET | [8-K](/filings/0000950170-25-002291.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-002291 |
| 2024-12-18 | 07:00 ET | [8-K](/filings/0001193125-24-280821.md) | 3.02 Unregistered sale of equity; 8.01 Other events | 0001193125-24-280821 |
| 2024-11-07 | 16:06 ET | [10-Q](/filings/0000950170-24-123296.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123296 |
| 2024-11-07 | 16:05 ET | [8-K](/filings/0000950170-24-123273.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123273 |
| 2024-08-14 | 08:03 ET | [8-K](/filings/0001193125-24-200252.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-200252 |
| 2024-08-07 | 08:05 ET | [8-K](/filings/0000950170-24-092289.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092289 |
| 2024-08-07 | 08:05 ET | [10-Q](/filings/0000950170-24-092288.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092288 |
| 2024-05-16 | 17:00 ET | [8-K](/filings/0000950170-24-061164.md) | 5.07 Shareholder vote results | 0000950170-24-061164 |
| 2024-05-08 | 16:11 ET | [10-Q](/filings/0000950170-24-055661.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055661 |
| 2024-05-08 | 16:05 ET | [8-K](/filings/0000950170-24-055622.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055622 |
| 2024-04-05 | 06:06 ET | [DEF 14A](/filings/0000950170-24-042052.md) | Proxy statement, period 2024-05-15 | 0000950170-24-042052 |
| 2024-04-03 | 16:55 ET | [8-K](/filings/0000950170-24-041225.md) | 8.01 Other events | 0000950170-24-041225 |
| 2024-03-26 | 16:12 ET | [8-K](/filings/0001193125-24-077611.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-077611 |
| 2024-02-27 | 17:23 ET | [10-K](/filings/0000950170-24-021423.md) | Annual report, period 2023-12-31 | 0000950170-24-021423 |
| 2024-02-27 | 16:05 ET | [8-K](/filings/0000950170-24-021095.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021095 |
| 2024-01-02 | 06:06 ET | [8-K](/filings/0001193125-24-000161.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-000161 |
| 2023-12-27 | 16:15 ET | [8-K](/filings/0001193125-23-303995.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-303995 |
| 2023-11-07 | 16:11 ET | [10-Q](/filings/0000950170-23-060253.md) | Quarterly report, period 2023-09-30 | 0000950170-23-060253 |
| 2023-11-07 | 16:05 ET | [8-K](/filings/0000950170-23-060230.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060230 |
| 2023-08-07 | 16:12 ET | [10-Q](/filings/0000950170-23-039074.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039074 |
| 2023-08-07 | 16:06 ET | [8-K](/filings/0000950170-23-039048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039048 |
| 2023-07-03 | 18:00 ET | [8-K](/filings/0000950170-23-031202.md) | 8.01 Other events | 0000950170-23-031202 |

Page 1 of 7. [Older](/companies/mnkd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.